These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11866314)

  • 1. Enteric and disseminated Campylobacter species infection during HIV disease: a persisting but significantly modified association in the HAART era.
    Manfredi R; Calza L; Chiodo F
    Am J Gastroenterol; 2002 Feb; 97(2):510-1. PubMed ID: 11866314
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteremia due to Campylobacter sp. in patients with HIV infection].
    Pigrau C; Almirante B; Bartolomé R; Pahissa A
    Med Clin (Barc); 1994 Jul; 103(6):239. PubMed ID: 7967875
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related pneumococcal lung disease: does highly active antiretroviral therapy or bacteremia modify radiologic appearance?
    Rizzi EB; Schininá V; Rovighi L; Cristofaro M; Bordi E; Narciso P; Bibbolino C
    AIDS Patient Care STDS; 2008 Feb; 22(2):105-11. PubMed ID: 18260801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
    Calza L; Manfredi R; Chiodo F
    Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unusual forms of bacteremia due to Campylobacter jejuni in patients with HIV infection].
    Knobel H; López-Colomes J; Saballs P; Drobnic L
    Med Clin (Barc); 1994 Jul; 103(6):239. PubMed ID: 7967876
    [No Abstract]   [Full Text] [Related]  

  • 15. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
    Tompkins JC; Witzig RS
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.